Clinical Trial Update: Metoclopramide to Treat Anemia in Patients With Myelodysplastic Syndrome (MDS) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating metoclopramide for anemia in patients with myelodysplastic syndromes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Metoclopramide (metoclopramide)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: WITHDRAWN